1850 related articles for article (PubMed ID: 15637983)
21. [Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis].
Repetto G; Poggi H; Harris P; Navarro H; Sánchez I; Guiraldes E; Pérez MA; Boza ML; Hunter B; Wevar ME; Mediavilla M; Foradori A
Rev Med Chil; 2001 Aug; 129(8):841-7. PubMed ID: 11680956
[TBL] [Abstract][Full Text] [Related]
22. A frame-shift mutation in the cystic fibrosis gene.
White MB; Amos J; Hsu JM; Gerrard B; Finn P; Dean M
Nature; 1990 Apr; 344(6267):665-7. PubMed ID: 1691449
[TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlation in cystic fibrosis: the role of modifier genes.
Salvatore F; Scudiero O; Castaldo G
Am J Med Genet; 2002 Jul; 111(1):88-95. PubMed ID: 12124743
[TBL] [Abstract][Full Text] [Related]
24. [Frequency of delta F508 mutation in Venezuelan patients with cystic fibrosis].
Morales-Machin A; Borjas-Fajardo L; Pineda L; González S; Delgado W; Zabala W; Fernández E
Invest Clin; 2004 Jun; 45(2):121-30. PubMed ID: 15211979
[TBL] [Abstract][Full Text] [Related]
25. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis.
Durno C; Corey M; Zielenski J; Tullis E; Tsui LC; Durie P
Gastroenterology; 2002 Dec; 123(6):1857-64. PubMed ID: 12454843
[TBL] [Abstract][Full Text] [Related]
26. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
Schwartz M
Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
[TBL] [Abstract][Full Text] [Related]
27. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
28. [Cystic fibrosis: molecular update and clinical implications].
Orozco L; Chávez M; Saldaña Y; Velázquez R; Carnevale A; González-del Angel A; Jiménez S
Rev Invest Clin; 2006; 58(2):139-52. PubMed ID: 16827266
[TBL] [Abstract][Full Text] [Related]
29. Spatial and temporal distribution of cystic fibrosis and of its mutations in Brittany, France: a retrospective study from 1960.
Scotet V; Gillet D; Duguépéroux I; Audrézet MP; Bellis G; Garnier B; Roussey M; Rault G; Parent P; De Braekeleer M; Férec C;
Hum Genet; 2002 Sep; 111(3):247-54. PubMed ID: 12215837
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel mutation of CFTR gene in a Korean patient with cystic fibrosis.
Ko JM; Kim GH; Kim KM; Hong SJ; Yoo HW
J Korean Med Sci; 2008 Oct; 23(5):912-5. PubMed ID: 18955805
[TBL] [Abstract][Full Text] [Related]
31. The cystic fibrosis gene and relationships to clinical status.
Campbell PW; Phillips JA
Semin Respir Infect; 1992 Sep; 7(3):150-7. PubMed ID: 1475539
[TBL] [Abstract][Full Text] [Related]
32. Mutations in CFTR gene and clinical correlation in Argentine patients with congenital bilateral absence of the vas deferens.
Levy EM; Granados P; Rawe V; Olmedo SB; Luna MC; Cafferata E; Pivetta OH
Medicina (B Aires); 2004; 64(3):213-8. PubMed ID: 15239534
[TBL] [Abstract][Full Text] [Related]
33. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
34. [Molecular basis of phenotype heterogeneity in cystic fibrosis].
Bienvenu T
Ann Biol Clin (Paris); 1997; 55(2):113-21. PubMed ID: 9180964
[TBL] [Abstract][Full Text] [Related]
35. CFTR genotypes in patients with normal or borderline sweat chloride levels.
Feldmann D; Couderc R; Audrezet MP; Ferec C; Bienvenu T; Desgeorges M; Claustres M; Mittre H; Blayau M; Bozon D; Malinge MC; Monnier N; Bonnefont JP; Iron A; Bieth E; Dumur V; Clavel C; Cazeneuve C; Girodon E
Hum Mutat; 2003 Oct; 22(4):340. PubMed ID: 12955726
[TBL] [Abstract][Full Text] [Related]
36. Severe deficiency of cystic fibrosis transmembrane conductance regulator messenger RNA carrying nonsense mutations R553X and W1316X in respiratory epithelial cells of patients with cystic fibrosis.
Hamosh A; Trapnell BC; Zeitlin PL; Montrose-Rafizadeh C; Rosenstein BJ; Crystal RG; Cutting GR
J Clin Invest; 1991 Dec; 88(6):1880-5. PubMed ID: 1721624
[TBL] [Abstract][Full Text] [Related]
37. Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
Cohn JA; Friedman KJ; Noone PG; Knowles MR; Silverman LM; Jowell PS
N Engl J Med; 1998 Sep; 339(10):653-8. PubMed ID: 9725922
[TBL] [Abstract][Full Text] [Related]
38. Non-classic cystic fibrosis associated with D1152H CFTR mutation.
Burgel PR; Fajac I; Hubert D; Grenet D; Stremler N; Roussey M; Siret D; Languepin J; Mely L; Fanton A; Labbé A; Domblides P; Vic P; Dagorne M; Reynaud-Gaubert M; Counil F; Varaigne F; Bienvenu T; Bellis G; Dusser D
Clin Genet; 2010 Apr; 77(4):355-64. PubMed ID: 19843100
[TBL] [Abstract][Full Text] [Related]
39. Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations.
Geborek A; Hjelte L
J Cyst Fibros; 2011 May; 10(3):187-92. PubMed ID: 21354377
[TBL] [Abstract][Full Text] [Related]
40. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis.
Ooi CY; Dorfman R; Cipolli M; Gonska T; Castellani C; Keenan K; Freedman SD; Zielenski J; Berthiaume Y; Corey M; Schibli S; Tullis E; Durie PR
Gastroenterology; 2011 Jan; 140(1):153-61. PubMed ID: 20923678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
